Role of Hormones in Mammary Cancer Initiation and Progression

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 1, 1998, Pages 49-61

  Russo, Irma H ^a   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Antiestrogens; Antiprogestins; Differentiation; Growth factors; Pregnancy; Rat mammary carcinomas; Steroid hormones

Indexed keywords

ESTROGEN; GROWTH PROMOTOR;

ANIMAL; BREAST TUMOR; CELL DIFFERENTIATION; CELL TRANSFORMATION; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; PREGNANCY; RAT; REVIEW; RISK FACTOR;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; ESTROGENS; FEMALE; GROWTH SUBSTANCES; HUMANS; MAMMARY NEOPLASMS, ANIMAL; PREGNANCY; RATS; RISK FACTORS;

EID: 0031597895     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018770218022     Document Type: Article

References (66)

1. M. P. Cunningham (1997). Giving life to numbers. C A Cancer J. Clin. 47:3-4.
2. S. L. Parker, T. Tong, S. Bolden, and P. A. Wingo (1997). Cancer statistics, 1997. C A Cancer J. Clin. 47:5-27.
3. S. E. King and D. Schottenfeld (1996). The epidemic of breast cancer in the U. S. - Determining the factors. Oncology 10:453-462.
4. L. A. Gaudette, C. Silberberg, C. A. Altmayer, and R. N. Gao (1996). Trends in breast cancer incidence and mortality. Health Reports. 8:29-40.
5. A. Seow, S. S. Duffy, M. A. McGee, J. Lee, and H. P. Lee (1996) . Breast cancer in Singapore: Trends in incidence 1968-1992. Int. J. Epidemiol. 25,40-45.
6. G. T. Beatson (1896). On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment, with illustrative cases. Lancet 2:104-107.
7. C. Huggins (1965). Two principles in endocrine therapy of cancers: Hormone deprival and hormone interference. Cancer Res. 25:1163-1167.
8. D. F. Easton, D. T. Bishop, D. Ford, and G. P. Crockford (1993). The breast cancer linkage consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52:678-701.
9. I. H. Russo and J. Russo (1996). Mammary gland neoplasia in long term rodent studies. Environ. Health Perspect. 104:938-967.
10. J. L. Kelsey and P. L. Horn-Ross (1993). Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol. Rev. 15:7-16.
11. E. Petrodidou, E. Syrigou, N. Toupadaki, X. Zavitsanos, and W. Willett (1996). Determinants of age at menarche as early life predictors of breast cancer risk. Int. J. Cancer 68:193-198.
12. M. Lambe, C.-C. Hsieh, H.-W. Chan, A. Ekbom, D. Trichopoulos, and H. O. Adami (1996). Parity, age at first and last birth, and risk of breast cancer: A population-based study in Sweden. Breast Cancer Res. Treat. 38:305-311.
13. S. L. Hancock, M. A. Tucker, and R. T. Hoppe (1993). Breast cancer after treatment of Hodgkin's disease. J. Natl. Cancer Inst. 85:25-31.
14. J. Russo and I. H. Russo (1994). Toward a physiological approach to breast cancer prevention. Cancer Epidemiol. Bio-markers Prev. 3:353-364.
15. S. Nandi, R. C. Guzman, and J. Yang (1995). Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Natl. Acad. Sci. USA 92:3650-3657.
16. J. Russo and I. H. Russo (1987). Biological and molecular bases of mammary carcinogenesis. Lab Invest. 57:112-137.
17. J. Russo, B. A. Gusterson, A. E. Rogers, I. H. Russo, S. R Wellings, and M. J. Van Zwieten (1990). Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62:1-32.
18. D. L. McCormick, C. B. Adamowski, A. Fiks, R. C. Moon (1981). Lifetime dose-response relationships for mammary tumor reduction by a single administration of N-methyl-N-nitrosurea. Cancer Res. 41:1690-1694.
19. C. J. Grubbs, D. R. Farnell, D. L. Hill, and K. C. McDonough (1985). Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J. Natl. Cancer Inst. 74:927-931.
20. W. P. Bocchinfuso and K. S. Korach (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mam. Gland Biol. Neoplasia 2:323-334.
21. R. C. Humphreys, J. Lydon, B. W. O'Malley, and J. M. Rosen (1997). Use of PRKO mice to study the role of progesterone in mammary gland development. J. Mam. Gland Biol. Neoplasia 2:343-353.
22. D. K. Sinha, J. E. Pazik, and T. L. Dao (1983). Progression of rat mammary development with age and its relationship to carcinogenesis by a chemical carcinogen. Int. J. Cancer 31:321-327.
23. J. R. Curtis (1982). The role of 7, 12 DMBA and three hormones in 7, 12 DMBA-induced rat mammary cancer: three hypotheses. Med. Hypoth. 9:489-507.
24. G. R. Cunha, P. Young, Y. K. Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombination experiments. J. Mam. Gland Biol. Neoplasia 2:393-401.
25. R. G. Edwards, C. M. Howles, and C. Macnamee (1990). Clinical endocrinology of reproduction. In E.-E Baulieu and P. A. Kelly (eds.), Hormones: From Molecules to Disease, Chapman and Hall, New York and London, pp. 457-476.
26. R. B. Dickson, M. Bano, M. D. Johnson, Y. E. Shi, I. Martinez-Lacaci, L. T. Amundadottir, B. Ziff, and J. Kurebayashi (1994). Steroid regulation of growth factors and protooncogenes in the normal and malignant mammary gland. In S. A. Khan and G. M. Stancel (eds.), Protooncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation, CRC Press, Boca Raton, Florida, pp. 143-74.
27. B. K. Vonderhaar (1988). Regulation of development of the normal mammary gland by hormones and growth factors. In M. E. Lippman and R. B. Dickson (eds.), Breast Cancer: Cellular and Molecular Biology, Kluwer, Boston, pp. 251-294.
28. I. H. Russo, J. Medado, and J. Russo (1989). Endocrine Influences on Mammary Structure and Development. In T. C. Jones, U. Mohr, and R. D. Hunt (eds.), Integument and Mammary Gland of Laboratory Animals, Springer Verlag, Berlin, pp. 252-266.
29. J. J. Peluso (1992). Morphologic and physiologic features of the ovary. In U. Mohr, D. L. Dungworth, and C. C. Capen (eds.), Pathobiology of the Aging Rat, ILSI Press, Washington, D.C., pp. 337-349.
30. S. Y. Yung (1988). Inhibins, activins and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocrine Rev. 9:267-293.
31. P. A. Kelly, B. I. Posner, T. Tsushima, and H. G. Friessen (1974). Studies of insulin, growth hormone and PRL binding: Ontogenesis, effects of sex and pregnancy Endocrinology 95:532-539
32. F. Labrie (1990). Glycoprotein hormones: Gonadotropins and thyrotropin. In E.-E Baulieu, and P. A. Kelly (eds.), Hormones: From Molecules to Disease, Chapman and Hall, New York and London, pp. 257-275.
33. T. K. Woodruff and K. E. Mayo (1990). Regulation of inhibin synthesis in the rat ovary. Ann. Rev. Physiol. 52:807-827.
34. D. T. Lincoln, F. Sinowatz, E. el-Hifnawi, R. L. Hughes, and M. Waters (1995). Evidence of a direct role for growth hormone (GH) in mammary gland proliferation and lactation. Anatomia, Histologia, Embryologia 24:107-115
35. J. Russo, Y. F. Hu, X. Ao, C. Grill, and I. H. Russo (1997). Critical appraisal of estrogens as carcinogenic agents in the human breast. Menopause Rev. (submitted).
36. M. M. King, P. McCoy, and I. H. Russo (1983). Dietary fat may influence DMBA-initiated mammary gland carcinogenesis by modification of mammary gland development. In D. A. Roe (ed.), Current Topics in Nutrition and Disease, Alan R. Liss, Inc. pp. 61-90.
37. J. Russo, L. K. Tay, and I. H. Russo (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 2:5-37.
38. G. Leclercq and J. C. Heuson (1979). Physiological and pharmacological effects of estrogens in breast cancer. Biochem. Biophys. Acta 560:427-455.
39. A. G. Jabara and A. G. Harcourt (1971). Effect of progesterone, ovariectomy and adrenalectomy on mammary tumors induced by 7,12-dimethylbenzathracene in Sprague-Dawley rats. Pathology 3:209-214.
40. A. Manni, J. E. Trujillo, and O. H. Pearson (1977). Predominant role of prolactin in stimulating the growth of 7,12-dimethylbe n-za(a)anthracene-induced rat mammary tumors. Cancer Res. 37:1216-1219.
41. C. W. Welsch (1978). Prolactin and the development and progression of early neoplastic mammary gland lesions. Cancer Res. 38:4054-4058.
42. C. W. Welsch, C. K. Brown, and M. Goodrich-Smith (1979). Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion. J. Natl. Cancer Inst. 63:1211-1214.
43. R. Das and B. K. Vonderhaar (1997). Prolactin as a mitogen in mammary cells. J. Mam. Gland Biol. Neoplasia 2:29-39.
44. A. E. Wakeling (1996). Physiological effects of pure antiestrogens. In J. R. Pasqualini and B. Katzenellenbogen (eds.), Hormone-Dependent Cancer, Marcel Dekker, Inc., New York, pp. 107-118.
45. R. C. Moon, G. J. Kelloff, C. J. Detrisac, V. E. Steele, C. F. Thomas, and C. C. Sigman (1992). Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. Anticancer Res. 12:1147-1153.
46. D. L. McCormick and R. C. Moon (1986). Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 7:193-196.
47. R. L. Stouffer (1990). Corpus luteum function and dysfunction. Clin. Obstet. Gynecol. 33:668-689.
48. C. K. W. Watts, N. R. C. Wilcken, J. A. Hamilton, K. J. E. Sweeney, A. Musgrove, and R. L. Sutherland (1996). Mechanisms of antiestrogen, progestin/antiprogestin, and retinoid inhibition of cell cycle progression in breast cancer cells. In J. R. Pasqualini and B. Katzenellenbogen (eds.), Hormone-Dependent Cancer, Marcel Dekker, Inc., New York, pp. 119-140.
49. I. H. Russo, P. Gimotty, M. Dupuis, and J. Russo (1989). Effect of the progestagen medroxyprogesterone acetate on mammary carcinogenesis. Brit. J. Cancer 59:210-216.
50. C. M. Aldaz, Q. Y. Liao, A. Paladugu, S. Rhem, and H. Wang (1996). Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol. Carcinog. 17:126-133.
51. Y. Lino, T. Ogawa, M. Yoshida, H. Ishikawa, M. Izuo, and H. Takikawa (1990). Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma. Jap. J. Clin. Oncol. 20:259-262.
52. R. D. Wiehle and J. L. Wittliff (1983). Alterations in sex-steroid hormone receptors during mammary gland differentiation in the rat. Comp. Biochem. Physiol. 76:409-417.
53. G. A. Jahn, M. Edery L. Belair, P. A. Kelly, and J. Dijiane (1991). PRL receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology 128:2976-2984.
54. C. J. Grubbs, M. M. Juliana, D. L. Hill, L. M. Whitaker (1986). Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res. 6:2395-2401.
55. D. R. Ciocca, A. Parente and J. Russo (1982). Endocrinologic milieu and susceptibility of the rat mammary gland to carcinogenesis. Am. J. Pathol. 109:47-56.
56. I. H. Russo, M. Koszalka, and J. Russo (1991). Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Brit. J. Cancer 64:481-484.
57. I. H. Russo, M. Koszalka, and J. Russo (1990). Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Brit. J. Cancer 62:243-247.
58. D. L. McCormick, K. V. Rao, W. D. Johnson, T. A. Bowman-Gram, V. E. Steele, R. A. Lubet, and G. J. Kellof (1996). Exceptional chemopreventive activity of low dose dehydroepiandrosterone in the rat mammary gland. Cancer Res. 56:1724-1726.
59. H. Ishikawa, Y. Lino, M. Izuo, and H. Takikawa (1986). Combined therapies with medroxyprogester one acetate (MPA) in DMBA-induced rat mammary cancer. Gan No Rinsho - Japanese J. Cancer Clinics 32:151-155.
60. J. Russo and I. H. Russo (1997). Role of Differentiation in the pathogenesis and prevention of breast cancer. Endocrine Related Cancer 4:7-21.
61. A. M. Soto and C. Sonnenschein (1987). Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocrine Rev. 48:52-58.
62. K. K. Huff, C. Knabbe, R. Lindsey, D. Kaufman, D. Bronzert, M. E. Lippman, and R. B. Dickson (1988). Multihormonal regulation of insulin-like growth factor-1-related protein in MCF-7 human breast cancer cells. Mol. Endocrinol. 2:200-208.
63. B. S. Katzenellenbogen, K. L. Kendra, M. J. Norman, and Y. Berthois (1987). Proliferation, hormonal responsiveness and estrogen receptor content of MCF-7 human breast cancer cells growth in the short-term and long-term absence of estrogens. Cancer Res. 47:4355-4360.
64. J. Gerdes, U. Schwab, H. Lemke and H. Stein (1983). Production of mouse-monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31:13-20.
65. G. Calaf, M. E. Alvarado, G. E Bonney, K. K. Amfoh, and J. Russo (1995). Influence of lobular development on breast epithelial cell proliferation and steroid hormone receptor content. Int. J. Oncol. 7:1285-1288.
66. E. Anderson, R. B. Clarke, and A. Howell (1998). Estrogen responsiveness and control of normal human breast development. J. Mam. Gland Biology Neoplasia 3:23-35.